Other Clinical Trial - Phase II Study of Extensive Clinical Target Volumes

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06056336` - Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma	Phase 2
Suspended	`NCT04084158` - A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.	Phase 2
Active, not recruiting	`NCT04242199` - Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors	Phase 1
Not yet recruiting	`NCT05561699` - Sequential Preoperative Penpulimab Combined With Chemoradiotherapy(CRT) for Locally Advanced Esophageal Squamous Cell Cancer	N/A
Active, not recruiting	`NCT04543617` - A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy	Phase 3
Recruiting	`NCT06190782` - Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor	Phase 3
Completed	`NCT05557955` - Identification of Breath Biomarkers in Esophageal Cancer
Recruiting	`NCT04045496` - A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors	Phase 1
Recruiting	`NCT04584008` - Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics	N/A
Not yet recruiting	`NCT03766178` - Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma	Phase 2
Recruiting	`NCT02913066` - S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma	Phase 2
Completed	`NCT02399306` - Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma	Phase 3
Completed	`NCT01605305` - Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer	Phase 2
Not yet recruiting	`NCT05552651` - Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma	Phase 2
Recruiting	`NCT05520619` - Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)	Phase 2
Terminated	`NCT03251417` - Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma	Phase 2
Recruiting	`NCT05990231` - Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy	Phase 2
Recruiting	`NCT04644250` - Combination of Toripalimab and Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma	Phase 2
Completed	`NCT02916511` - Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma	Phase 2
Terminated	`NCT04032704` - A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors	Phase 2

NCT number	NCT02384811
Study type	Interventional
Source	Fudan University
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	December 2014
Completion date	July 2019

Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms